Literature DB >> 9593286

Ten novel 11q23 chromosomal partner sites. European 11q23 Workshop participants.

C J Harrison1, A Cuneo, R Clark, B Johansson, M Lafage-Pochitaloff, F Mugneret, A V Moorman, L M Secker-Walker.   

Abstract

The MLL gene located at 11q23 has been described as a 'promiscuous' gene due its involvement with a large number of genetic partners. The EU Concerted Action Workshop on 11q23 provided 550 cases for study of which 82 showed abnormalities which did not involve the established translocations or deletion of 11q23. In these 'other' cases, which included inversions and duplications, 11q23 was found to be involved with 25 chromosome partners of which 10 had not been previously reported. These were 1q31, 4p11, 6q13, 8q21, 10q22, 10q25, 11q11, 11q21, 13q34 and 18q23. This study demonstrated the value of the Workshop, in confirming the diversity of chromosomal partner sites involved with 11q23 and in the identification of new partners.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9593286     DOI: 10.1038/sj.leu.2401017

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  12 in total

1.  Therapy-related acute myeloid leukemia 6 years after clonal detection of inv(11)(q21q23) and MLL gene rearrangement.

Authors:  Naoko Takei; Kazumi Suzukawa; Harumi Yamamoto Mukai; Takayoshi Itoh; Yasushi Okoshi; Yasuhiro Yoda; Toshiro Nagasawa
Journal:  Int J Hematol       Date:  2006-04       Impact factor: 2.490

2.  The human formin-binding protein 17 (FBP17) interacts with sorting nexin, SNX2, and is an MLL-fusion partner in acute myelogeneous leukemia.

Authors:  U Fuchs; G Rehkamp; O A Haas; R Slany; M Kōnig; S Bojesen; R M Bohle; C Damm-Welk; W D Ludwig; J Harbott; A Borkhardt
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

3.  First description of the t(10;11)(q22;q23)/MLL-TET1 translocation in a T-cell lymphoblastic lymphoma, with subsequent lineage switch to acute myelomonocytic myeloid leukemia.

Authors:  Antoine Ittel; Eric Jeandidier; Catherine Helias; Nathalie Perrusson; Catherine Humbrecht; Bruno Lioure; Isabelle Mazurier; Caroline Mayeur-Rousse; Amandine Lavaux; Sylvie Thiebault; Felix Lerintiu; Carine Gervais; Laurent Mauvieux
Journal:  Haematologica       Date:  2013-12       Impact factor: 9.941

4.  Genomic breakpoints and clinical features of MLL-TET1 rearrangement in acute leukemias.

Authors:  Sang-Guk Lee; Sun Young Cho; Min Jin Kim; Seung Hwan Oh; Eun Hae Cho; Sanggyu Lee; Eun Jung Baek; Jung Hye Choi; Stefan K Bohlander; Laurence Lode; Steven Richebourg; Hwi-Joong Yoon; Rolf Marschalek; Claus Meyer; Tae Sung Park
Journal:  Haematologica       Date:  2012-10-25       Impact factor: 9.941

5.  Molecular characterization and clinical impact of t(11;15)(q23;q14-15) MLL-CASC5 rearrangement.

Authors:  John Jeongseok Yang; Tae Sung Park; Seung-Tae Lee; Ja-Young Seo; Seung Hwan Oh; Eun Hae Cho; Sabine Strehl; Nora Mühlegger; Michael N Dworzak; Jan Zuna; Dagmar Pospisilova; Claus Meyer; Rolf Marschalek; Hee-Jin Kim; Sun-Hee Kim
Journal:  Haematologica       Date:  2014-01       Impact factor: 9.941

6.  The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5q.

Authors:  A Borkhardt; S Bojesen; O A Haas; U Fuchs; D Bartelheimer; I F Loncarevic; R M Bohle; J Harbott; R Repp; U Jaeger; S Viehmann; T Henn; P Korth; D Scharr; F Lampert
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

7.  Leukemic HRX fusion proteins inhibit GADD34-induced apoptosis and associate with the GADD34 and hSNF5/INI1 proteins.

Authors:  H T Adler; R Chinery; D Y Wu; S J Kussick; J M Payne; A J Fornace; D C Tkachuk
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

Review 8.  Molecular pathogenesis of MLL-associated leukemias.

Authors:  Mariko Eguchi; Minenori Eguchi-Ishimae; Mel Greaves
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

Review 9.  DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders.

Authors:  Hanae Sato; Justin C Wheat; Ulrich Steidl; Keisuke Ito
Journal:  Front Oncol       Date:  2016-08-22       Impact factor: 6.244

10.  A rare case of pediatric T lymphoblastic leukemia with t(11;17)(q23;q21) involving mixed-lineage leukemia gene rearrangement.

Authors:  Heyjin Kim; Jin Kyung Lee; Jun Ah Lee; Young Jun Hong; Seok Il Hong; Heui Seung Jo; Yoon Hwan Chang
Journal:  Ann Lab Med       Date:  2016-01       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.